Corneal Cross-Linking Treatment
Corneal cross-linking is a minimally invasive treatment to treat progressive
keratoconus (and, sometimes, other conditions that cause a similar weakening of the
cornea). The corneal cross-linking treatment strengthens and stabilizes the cornea
through the creation of new links between collagen fibres. This two-stage treatment
is followed directly by a regulated exposure to ultraviolet light for specialized
riboflavin (Vitamin B) drops on the surface of the eye.
Corneal Cross-Linking Treatment at KABERA
Corneal cross-linking takes about 2 hours to prepare, therapy and recuperate
properly in an office environment. The best part about this is that the process is
minimally invasive using simply eye drops, ultraviolet light and a painless bubbling
off the corneal surface cells. This technology is a game-changer and our patients are
proud to get it!
In this procedure, the thin outer layer (epithelium) of the cornea is removed to allow
the liquid riboflavin to more easily penetrate the deeper corneal tissue.
In this procedure (also called transepithelial cross-linking), the protective corneal
epithelium is left intact, making it a less invasive procedure than cross-linking with